DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Akebia Therapeutics Q4 EPS $(0.79) Misses $(0.47) Estimate, Sales $69.555M May Not Compare To $93.15M Estimate

Akebia Therapeutics (NASDAQ:AKBA) reported quarterly losses of $(0.79) per share which missed the analyst consensus estimate of $(0.47) by 68.09 percent. The company reported quarterly sales of $69.555 million which

Benzinga · 03/10/2020 11:50

Akebia Therapeutics (NASDAQ:AKBA) reported quarterly losses of $(0.79) per share which missed the analyst consensus estimate of $(0.47) by 68.09 percent. The company reported quarterly sales of $69.555 million which missed the analyst consensus estimate of $93.15 million by 25.33 percent.